My SciELO
Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Ars Pharmaceutica (Internet)
On-line version ISSN 2340-9894
Abstract
ALMEIDA-CARNEIRO, Rayssa et al. Toxic effects of antineoplastic therapy in patients breast cancer in Caruaru-PE oncology center. Ars Pharm [online]. 2018, vol.59, n.4, pp.221-226. Epub Oct 19, 2020. ISSN 2340-9894. https://dx.doi.org/10.30827/ars.v59i4.8113.
Objective:
to evaluate the main clinical symptoms associated with the toxic effects of antineoplastic therapy in women with breast cancer at a cancer treatment center in the city of Caruaru/PE.
Methods:
This is an analytical and transversal study with a quantitative approach, carried out between September and December 2017, whose data source was the medical records of the patients included in the study.
Results:
the majority of the sample consisted of women aged between 41 and 50 years (28.6%). This study made it possible to identify the most frequent histological type of breast cancer, with invasive ductal carcinoma observed in 88.6% and the most used protocol was Doxorubicin, Cyclophosphamide and Paclitaxel. Alopecia (91.4%) was the main adverse event observed in patients.
Conclusion:
it was possible to verify that the observation of these effects, allows a better control during the therapy, enabling improvement of the time and quality of life.
Keywords : Antineoplastic Agents; Breast Neoplasms; Drug-Related Side Effects and Adverse Reactions; Cancer; Medical oncology.